The latest publication from my lab is a new intratumoral immunotherapy delivery platform, which achieves 6 days of intratumoral drug release, from a single injection. Tumors can be “painted” with drug using a needle, and the drug stays exactly where it’s injected, maximizing immune activation in the tumor, while reducing systemic toxicity.
Comments
The latest publication from my lab is a new intratumoral immunotherapy delivery platform, which achieves 6 days of intratumoral drug release, from a single injection. Tumors can be “painted” with drug using a needle, and the drug stays exactly where it’s injected, maximizing immune activation in the tumor, while reducing systemic toxicity.